Drug Shortage Report for WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE

Last updated on 2019-03-01 History
Report ID 30976
Drug Identification Number 02453703
Brand name WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE
Common or Proper name Acetaminophen/Codeine/Caffeine
Company Name JAMP PHARMA CORPORATION
Market Status DORMANT
Active Ingredient(s) ACETAMINOPHEN CODEINE PHOSPHATE CAFFEINE
Strength(s) 300MG 8MG 15MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N02BE
ATC description OTHER ANALGESICS AND ANTIPYRETICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-11-27
Estimated end date 2020-12-31
Actual end date
Shortage status Actual shortage
Updated date 2019-03-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-11-28 English Compare
v2 2017-11-28 French Compare
v3 2018-03-09 English Compare
v4 2018-03-09 French Compare
v5 2018-10-15 English Compare
v6 2018-10-15 French Compare
v7 2018-12-19 English Compare
v8 2018-12-19 French Compare
v9 2019-03-01 English Compare
v10 2019-03-01 French Compare
v11 2019-03-01 English Compare
v12 2019-03-01 French Compare
v13 2019-03-01 English Compare
v14 2019-03-01 French Compare

Showing 1 to 14 of 14